The Obesity (SLIM) ETF Holdings & Analysis
ETFOther
What SLIM does
This investment fund aims to mirror the performance, prior to fees and expenses, of a specific benchmark index. This index is designed to track companies worldwide that are poised to generate revenue from addressing or serving the obese population. These companies span various sectors, including biotechnology, pharmaceuticals, healthcare, and medical device firms primarily focused on obesity and its related health conditions. The index also includes businesses that provide weight loss programs, dietary supplements, or specialize in plus-sized apparel. The fund allocates a significant portion—at least 80% of its net assets—to the stocks that make up the Solactive Obesity Index. It is important to note that this is a non-diversified investment vehicle.
Fund profile
Sector allocation
| Consumer Cyclical | 3.89% |
| Consumer Defensive | 4.25% |
| Healthcare | 91.86% |
PortView Portfolio Insights
PortView analyzes how SLIM fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze SLIM in PortView →Related securities
Related stocks
Frequently asked questions
- What does SLIM track?
- SLIM is the The Obesity ETF, a Other ETF.
- What is the expense ratio of SLIM?
- Expense ratio data for SLIM is shown on the page when available from our data provider.
- What are the largest holdings in SLIM?
- SLIM's top holdings are listed on this page when available.
- How can PortView analyze SLIM overlap with other ETFs?
- PortView computes the holdings overlap between SLIM and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.